De Novo Sirolimus-Based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side Effects-Reference-Cited by-同舟云学术

De Novo Sirolimus-Based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side Effects

Published:2007-05-15 Issue:9 Volume:83 Page:1162-1168
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Toso Christian,Meeberg Glenda A.,Bigam David L.,Oberholzer Jose,Shapiro A M. James,Gutfreund Klaus,Ma Mang M.,Mason Andrew L.,Wong Winnie W. S.,Bain Vincent G.,Kneteman Norman M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference32 articles.

1. Maintenance immunosuppression with Target-of-Rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.;Kauffman;Am J Transplant,2005

2. Activity of rapamycin (AY-22,989) against transplanted tumors.;Eng;J Antibiot,1984

3. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor.;Guba;Nat Med,2002

4. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.;Guba;Blood,2005

5. Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth.;Schumacher;World J Gastroenterol,2005

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capecitabine mitigates cardiac allograft rejection via inhibition of TYMS-Mediated Th1 differentiation in mice;International Immunopharmacology;2024-11

2. Risk factors for incisional hernia after liver transplantation in the era of mammalian target of rapamycin inhibitors use: a retrospective study of living donor liver transplantation dominant center in Korea;Annals of Surgical Treatment and Research;2024

3. Liver transplantation: the recipient;Living Donor Organ Transplantation;2024

4. Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus;Frontiers in Transplantation;2023-04-20

5. A mixed blessing for liver transplantation patients — Rapamycin;Hepatobiliary & Pancreatic Diseases International;2023-02